Sequential changes in von Willebrand factor and soluble thrombomodulin in acute ischemic stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 10, Issue 6, 2001, Pages 257-264

  Nomura, Eiichi ^a   Kohriyama, Tatsuo ^b   Kozuka, Kazuko ^b   Nakamura, Shigenobu ^b   Kajikawa, Hiroshi ^a  

^a Suiseikai Kajikawa Hospital   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute ischemic stroke; Thrombomodulin; Von willebrand factor; White blood cell

Indexed keywords

THROMBOMODULIN; VON WILLEBRAND FACTOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY DISEASE; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; STROKE; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

EID: 0035741555     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2001.123776     Document Type: Article

References (50)

1. Factor-VIII complex and endothelial damage
2. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon
3. The role of vascular endothelium in the pathogenesis of connective tissue disease: Endothelial injury, activation, participation and response
4. von Willebrand factor and the endothelium in vascular disease
5. von Willebrand factor: A marker of endothelial dysfunction in vascular disorders?
6. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
7. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent diabetes mellitus
8. Association between carotid atherosclerosis and hemostatic markers in patients with cerebral small artery disease
9. Haemostatic variables and the outcome of myocardial infarction
10. von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
11. Blood coagulation studies in 45 patients with ischemic cerebrovascular disease and 44 patients with venous thromboembolic disease
12. A study of hemostasis in ischemic cerebrovascular disease. I. Abnormalities in factor VIII and antithrombin
13. Platelet function tests in thrombotic cerebrovascular disorders
14. Increased factor VIII related antigen in cerebral thrombosis
15. Changes of von Willebrand factor and antithrombin III levels in acute stroke: Difference between thrombotic and haemorrhagic stroke
16. von Willebrand factor and factor VIII:C in acute cerebrovascular disease. Relationship to stroke subtype and mortality
17. Soluble intercellular adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke
18. Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome
19. Haemostasis factors in angina pectoris: Relation to gender, age and acute-phase reaction. Results of the ECAT angina pectoris study group
20. Thrombomodulin is found on endothelium of arteries, vein, capillaries and lymphatics and on syncytiotrophoblast of human placenta
21. The roles of protein C and thrombomodulin in the regulation of blood coagulation
22. Control of thrombin mediated cleavage of protein S
23. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V
24. Soluble markers of endothelial cell function
25. Levels of plasma thrombomodulin are increased in atheromatous arterial disease
26. Thrombomodulin. Biology and potential cardiovascular applications
27. Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro
28. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells
29. Interleukin I induces endothelial cell procoagulant while supressing cell-surface anticoagulant activity
30. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
31. Cytokines and acute-phase response in acute stroke
32. Peripheral white blood cell count in cerebral ischemic infarction
33. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: Kinetics of secretion and relation to the extent of brain damage and outcome of disease
34. Increased cytokine release from peripheral blood cells after acute stroke
35. Proinflammatory cytokines and early neurological worsening in ischemic stroke
36. Experience from a multicentre stroke register: A preliminary report
37. Classification and natural history of clinically identifiable subtypes of cerebral infarction
38. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage
39. Cerebrospinal fluid and peripheral white blood cell response to acute cerebral ischemia
40. Persistent inflammatory response in stroke survivors
41. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation
42. Plasma thrombomodulin in liver diseases
43. Plasma thrombomodulin in health and diseases
44. Increased thrombomodulin values in plasma of diabetic men with microangiopathy
45. Serum thrombomodulin and anticardiolipin antibodies in patients with systematic lupus erytematuus
46. Increased levels of plasma thrombomodulin in chronic myelogenous leukemia
47. Increased plasma thrombomodulin in cancer patients
48. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain
49. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia
50. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study